Effect of Antibiotic Treatment on Establishment and Elimination of Intestinal Colonization by KPC-producing Klebsiella Pneumoniae in Mice
Overview
Affiliations
An understanding of the impact of antibiotics on the intestinal reservoir of KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is important to prevent its emergence. We used a mouse model to examine the effect of antibiotic treatment on the establishment and elimination of intestinal colonization with KPC-Kp. Mice (10 per group) received subcutaneous antibiotics daily for 8 days. On day 3 of treatment, 10(3) CFU of KPC-Kp was given orogastrically, and concentrations of KPC-Kp in stool were monitored. Additional experiments assessed the effects of antibiotic treatment on concentrations of total anaerobes and Bacteroides spp. in stool and the efficacy of orogastric gentamicin and polymyxin E in suppressing KPC-Kp colonization. Of four antibiotics with minimal activity against the KPC-Kp test strain (MIC ≥ 16 μg/ml), those that suppressed total anaerobes and bacteroides (i.e., clindamycin and piperacillin-tazobactam) promoted colonization by KPC-Kp (P < 0.001), whereas agents that did not suppress total anaerobes or bacteroides (i.e., ciprofloxacin and cefepime) did not (P = 0.35). Of two agents with moderate activity against the KPC-Kp test strain, ertapenem (MIC, 4 μg/ml) did not promote colonization by KPC-Kp, whereas tigecycline (MIC, 3 μg/ml) did (P < 0.001), despite not reducing levels of total anaerobes or bacteroides. Orogastric treatment with gentamicin and polymyxin E suppressed KPC-Kp to undetectable levels in the majority of mice. These data suggest that antibiotics that disturb the intestinal anaerobic microflora and lack significant activity against KPC-Kp promote colonization by this organism. The administration of nonabsorbed oral antibiotics may be an effective strategy to suppress colonization with KPC-Kp.
Hausman B, Memic S, Cadnum J, Zink E, Wilson B, Donskey C Pathog Immun. 2024; 9(2):194-204.
PMID: 39345792 PMC: 11432534. DOI: 10.20411/pai.v9i2.711.
Eddoubaji Y, Aldeia C, Campos-Madueno E, Moser A, Kundlacz C, Perreten V Front Microbiol. 2024; 15:1381051.
PMID: 38659985 PMC: 11039899. DOI: 10.3389/fmicb.2024.1381051.
Deciphering the gastrointestinal carriage of .
Bray A, Zafar M Infect Immun. 2024; 92(9):e0048223.
PMID: 38597634 PMC: 11384780. DOI: 10.1128/iai.00482-23.
Animal models of mucosal infections.
Assoni L, Couto A, Vieira B, Milani B, Lima A, Converso T Front Microbiol. 2024; 15:1367422.
PMID: 38559342 PMC: 10978692. DOI: 10.3389/fmicb.2024.1367422.
Antibiotics in anesthesia and critical care.
Premachandra A, Moine P Ann Transl Med. 2024; 12(1):6.
PMID: 38304898 PMC: 10777233. DOI: 10.21037/atm-22-5585.